Posterior wall isolation in persistent atrial fibrillation feasibility, safety, durability, and efficacy

René Worck, Samuel K Sørensen, Arne Johannessen, Martin Ruwald, Martin Haugdal, Jim Hansen, René Worck, Samuel K Sørensen, Arne Johannessen, Martin Ruwald, Martin Haugdal, Jim Hansen

Abstract

Introduction: Posterior wall isolation (PWI) added to pulmonary vein isolation (PVI) is increasingly used despite limited evidence of clinical benefit. We investigated the feasibility, durability, and efficacy of index-procedure PVI + PWI radio frequency ablation (RFA) in patients with persistent atrial fibrillation (PeAF).

Methods and results: Twenty-four patients with PeAF participated in the prospective PeAF-Box study and underwent RFA with wide area circumferential ablation, roof- and inferior lines to achieve PVI + PWI at index procedure. Follow-up included monitoring by an implantable cardiac monitor, esophagoscopy and mandated invasive lesion-reassessment at 6 months. PWI was achieved at minor procedural cost in all patients following PVI. In 33% of patients a median of three ablations in the narrow zone between the center of the posterior wall (PW) and the posterior right carina was pivotal for swift achievement of PWI. At the 6-month reassessment procedure 85% (95% confidence interval [CI]: 77%-92%) of pulmonary veins (PVs) and 46% (95% CI: 26%-67%) of PWs remained durably isolated. AF recurred in 25% and was associated with PV-reconnection (p = .02) but not PW-reconnection (p = .27). AF-burden was 0% (interquartile range [IQR]: 0%-0%) overall and after recurrence 1% (IQR: 0%-7%).

Conclusion: Index procedure PVI + PWI for PeAF was feasible when recognizing that limited ablation in a PW center-to-right-carina zone was required in a subset of patients. Despite limited chronic PWI durability this strategy was followed by low AF-burden. A PVI + PWI strategy appears promising in ablation for PeAF.

Trial registration: ClinicalTrials.gov NCT05045131.

Keywords: AF burden; center-right zone (of left atrial posterior wall); implanted continuous rhythm monitor; mandated invasive reassessment; persistent atrial fibrillation; posterior wall.

© 2022 The Authors. Journal of Cardiovascular Electrophysiology published by Wiley Periodicals LLC.

Figures

Figure 1
Figure 1
PVI + PWI. (A) Planned lesion set with WACA segments 1–12 and Roof/Inferior segments PW1‐PW6. (B) Posterior view of actual lesion set to obtain PVI + PWI in a patient where center‐right zone ablation was required. PVI, pulmonary vein isolation; PWI, posterior wall isolation
Figure 2
Figure 2
Chronic durability of PVI + PWI after 6 months: (A) Bipolar voltage map showing durable PVI but reconnected PW with lesions (red and pink tags) to reestablish PWI. (B) Durable PVI + PWI. (C) Location and frequency of conduction gaps at 6 months mandated reassessment. PVI, pulmonary vein isolation; PWI, posterior wall isolation
Figure 3
Figure 3
Time to first recurrence of AF detected on ICM. Bar depicts 90‐day blanking period postablation. ICM, implantable cardiac monitor

References

    1. Bai R, Di Biase L, Mohanty P, et al. Proven isolation of the pulmonary vein antrum with or without left atrial posterior wall isolation in patients with persistent atrial fibrillation. Heart Rhythm. 2016;13:132‐140.
    1. Chilukuri K, Scherr D, Dalal D, et al. Conventional pulmonary vein isolation compared with the ‘box isolation’ method: a randomized clinical trial. JIntervCard Electrophysiol. 2011;32:137‐146.
    1. Calkins H, Hindricks G, Cappato R, et al HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace. 2017;2018(20):e1‐160.
    1. Thiyagarajah A, Kadhim K, Lau DH, et al. Feasibility, safety, and efficacy of posterior wall isolation during atrial fibrillation ablation: a systematic review and meta‐analysis. Circ Arrhythm Electrophysiol. 2019;12:e007005.
    1. Spertus J, Dorian P, Bubien R, et al. Development and validation of the atrial fibrillation effect on QualiTy‐of‐Life (AFEQT) questionnaire in patients with atrial fibrillation. Circ Arrhythm Electrophysiol. 2011;4:15‐25.
    1. Arentz T, Macle L, Kalusche D, et al. ‘Dormant’ pulmonary vein conduction revealed by adenosine after ostial radiofrequency catheter ablation. J Cardiovasc Electrophysiol. 2004;15:1041‐1047.
    1. Sørensen SK, Johannessen A, Worck R, Hansen ML, Hansen J. Radiofrequency versus cryoballoon catheter ablation for paroxysmal atrial fibrillation: durability of pulmonary vein isolation and effect on atrial fibrillation burden: the RACE‐AF randomized controlled trial. Circ Arrhythm Electrophysiol. 2021;14:e009573.
    1. Yarlagadda B, Deneke T, Turagam M, et al. Temporal relationships between esophageal injury type and progression in patients undergoing atrial fibrillation catheter ablation. Heart Rhythm. 2019;16:204‐212.
    1. Kuwahara T, Takahashi A, Takahashi Y, et al Incidences of esophageal injury during esophageal temperature monitoring: a comparative study of a multi‐thermocouple temperature probe and a deflectable temperature probe in atrial fibrillation ablation. Journal of Interventional Cardiac Electrophysiology. 39. Springer Nature B.V; 2014:251‐257.
    1. Sanders P, Hocini M, Jaïs P, et al. Complete isolation of the pulmonary veins and posterior left atrium in chronic atrial fibrillation. Long‐term clinical outcome. Eur Heart J. 2007;28:1862‐1871.
    1. Chen J, Off MK, Solheim E, Schuster P, Hoff PI, Ohm O‐J. Treatment of atrial fibrillation by silencing electrical activity in the posterior inter‐pulmonary‐vein atrium. Europace. 2008;10:265‐272.
    1. McLellan AJA, Prabhu S, Voskoboinik A, et al. Isolation of the posterior left atrium for patients with persistent atrial fibrillation: routine adenosine challenge for dormant posterior left atrial conduction improves long‐term outcome. Europace. 2017;19:1958‐1966.
    1. Ho SY, Sanchez‐Quintana D, Cabrera JA, Anderson RH. Anatomy of the left atrium: implications for radiofrequency ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 1999;10:1525‐1533.
    1. Pambrun T, Duchateau J, Delgove A, et al. Epicardial course of the septopulmonary bundle: anatomical considerations and clinical implications for roof line completion. Heart Rhythm. 2021;18:349‐357.
    1. Ho SY, Anderson RH, Sánchez‐Quintana D. Atrial structure and fibres: morphologic bases of atrial conduction. Cardiovasc Res. 2002;54:325‐336.
    1. Markman TM, Hyman MC, Kumareswaran R, et al. Durability of posterior wall isolation after catheter ablation among patients with recurrent atrial fibrillation. Heart Rhythm. 2020;17:1740‐1744.
    1. Cochet H, Nakatani Y, Sridi‐Cheniti S, et al. Pulsed field ablation selectively spares the oesophagus during pulmonary vein isolation for atrial fibrillation. EP Europace. 2021;23:1391‐1399.
    1. Das M, Wynn GJ, Saeed Y, et al. Pulmonary vein re‐isolation as a routine strategy regardless of symptoms: the PRESSURE randomized controlled trial. JACC Clin Electrophysiol. 2017;3:602‐611.
    1. De Pooter J, Strisciuglio T, El Haddad M, et al. Pulmonary vein reconnection no longer occurs in the majority of patients after a single pulmonary vein isolation procedure. JACC: Clinical Electrophysiology. 2019;5:295‐305.
    1. Balabanski T, Brugada J, Arbelo E, et al. Impact of monitoring on detection of arrhythmia recurrences in the ESC‐EHRA EORP atrial fibrillation ablation long‐term registry. EP Europace. 2019;21:1802‐1808.
    1. Verma A, Jiang CY, Betts TR, et al. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med. 2015;372:1812‐1822.
    1. Andrade JG, Deyell MW, Verma A, Macle L, Khairy P. The cryoballoon vs irrigated radiofrequency catheter ablation (CIRCA‐DOSE) study results in context. Arrhythm Electrophysiol Rev. 2020;9:34‐39.
    1. Duytschaever M, De Pooter J, Demolder A, et al. Long‐term impact of catheter ablation on arrhythmia burden in low‐risk patients with paroxysmal atrial fibrillation: the CLOSE to CURE study. Heart Rhythm. 2020;17:535‐543.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren